济南早泄土治疗方法-【济南附一医院】,济南附一医院,济南早泄治疗的了不,济南怎么治疗龟头敏感,济南阳痿早泄到底好不好治,济南阴茎尿道口有白色,济南尿道感染是不是治不好,济南包皮手术挂什么科室
济南早泄土治疗方法济南五分钟就射精了,济南泌尿系感染不治,济南正常包茎,济南感染性疾病专科,济南射精怎么个快怎么办,济南男早泄怎么调理,济南前列腺增生肥大的症状
BAODING, Feb. 2, (Xinhua) -- All-out efforts should be made to combat drought for a summer grain harvest, said Chinese President Hu Jintao Wednesday in an inspection tour to north China's Hebei Province."We need to adopt comprehensive measures to ensure supply of capital, technologies, facilities and materials to enable winter wheat to safely grow through the winter," said Hu, when inspecting drought conditions at a wheat field in Xishanbei Township of Baoding City, Hebei.Over the past three months, North China has been hit by severe drought, seriously threatening normal agricultural production.Hu, who is also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, made the inspection visit in Baoding from Tuesday to Wednesday, to welcome the Spring Festival, or China's Lunar New Year, with local officials and residents.Hu beat a drum together with villagers during a new year celebration in Shijiatong Village, Xishanbei Township of Baoding.The president visited the home of Yan Deshu, an aged CPC member in the village, and pasted the Chinese character "Fu", meaning fortune and happiness, on the gate of Yan's yard.Hu also visited a long-distance coach station in Baoding, and extended Spring Festival greetings to passengers, station workers and volunteers.Hu inspected a unit of armed police in Baoding and made Chinese dumplings together with the officers and soldiers.
SAN FRANCISCO, March 7 (Xinhua) -- The world's leading hard rive producer Western Digital Corp. on Monday announced that it has agreed to buy Hitachi Ltd.'s hard disk drive unit for about 4. 3 billion U.S. dollars, a move that will create a dominant player in the industry.Western Digital said that it plans to acquire Hitachi Global Storage Technologies, a wholly-owned subsidiary of Hitachi Ltd., in cash and stock.The proposed combination will result in a customer-focused storage company with the industry's broadest product lineup backed by a rich technology portfolio, Western Digital said.According to their agreement, the resulting company will retain the Western Digital name and remain headquartered in Irvine in the U.S. state of California.The transaction has been approved by the board of directors of each company and is expected to close during the third quarter of 2011.With the purchase, Western Digital will claim 49.6 percent share of global hard disk drive unit shipments based on latest quarterly statistics, compared to 29.4 percent for Seagate Technology LLC, the industry's No. 2 supplier, research firm iSuppli pointed out.The deal will give Western Digital a lead of 20.2 percentage points over Seagate, up from a mere 2 points without the acquisition, iSuppli said in a research note released Monday.The acquisition will also allow Western Digital to enter the critical enterprise hard disk drive segment, where it currently is only a marginal player.Analysts believed that the purchase might be a consequence of declining hard disk drive shipments, which are being impacted by the rising sales of tablet computers, which don't use hard disk drives and are cutting into the sales of mobile PCs, a major market for hard drives."Amid weaker industry conditions, organic sales growth is more difficult to achieve, prompting hard disk drive suppliers to engage in acquisitions to gain market share," iSuppli noted.
LOS ANGELES, April 14 (Xinhua) -- Customer complaints of an "uncharacteristic odor" prompted Johnson & Johnson to recall about 57,000 bottles of the prescription anti-seizure drug, Johnson & Johnson announced on Thursday.The recall affects two lots of the Topamax 100 mg tablets made by the company's Ortho-McNeil Neurologics division, Johnson & Johnson said.The drug was shipped and distributed between Oct. 19, 2010 and Dec. 28, 2010 in the United States and Puerto Rico.There were four consumer complaints about an odor believed to be caused by trace amounts of the chemical TBA (2,4,6 tribromoanisole), which is applied to wooden pallets used to transport and store packaging materials, Johnson & Johnson said.The recall is not expected to lead to a product shortage at the market, Ortho-McNeil Neurologics said.Similar complaints of a moldy, musty odor have led to the recalls of millions of bottles of Tylenol, Motrin and Benadryl products earlier.Last month, the U.S. government said it was taking over three Tylenol plants operated by McNeil, and the Food and Drug Administration launched a criminal investigation into safety issues at the factories, CNN reported.
BEIJING, Feb. 12 (Xinhua) -- Sales revenue of Beijing's auto market in 2011 might shrink by 60 billion yuan (about 9.1 billion U.S. dollars) due to the city limiting the number of cars purchased each month, a commerce official said Saturday.Car sales revenue will drop to 100 billion yuan in 2011 from last year's 160 billion yuan, Wang Shuxia, chief for marketing section with the Beijing Municipal Commission of Commerce, told a working meeting of the commission.A control on car purchases introduced this year limits new car license plates to 240,000 in 2011, said Wang.In 2010, more than 800,000 new cars drove onto Beijing's roads, worsening the chronic gridlock in this Chinese national capital of nearly 5 million automobiles.Wang estimated that Beijing's car sales this year will hit 580,000 units, as some cars will be sold to buyers outside of Beijing while others will be purchased by buyers who are replacing older cars.Car owners who replace their old vehicles can obtain car license plates directly without taking part in the lottery that allots 20,000 new plates each month.
WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.